CELL THERAPEUTICS INC's ticker is CTIC and the CUSIP is 150934883. A total of 66 filers reported holding CELL THERAPEUTICS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2013 | $18,000 | – | 17,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 400,000 | $1,360,000 | 0.31% |
| TFS CAPITAL LLC | 1,351,073 | $4,594,000 | 0.30% |
| Geduld E E | 100,000 | $340,000 | 0.18% |
| OXFORD ASSET MANAGEMENT LLP | 1,429,215 | $4,859,000 | 0.14% |
| EAGLE ASSET MANAGEMENT INC | 6,718,484 | $22,842,000 | 0.13% |
| First Heartland Consultants, Inc. | 74,624 | $254,000 | 0.12% |
| WASHINGTON TRUST Co | 410,616 | $1,396,000 | 0.10% |
| FIRST NEW YORK SECURITIES LLC /NY | 50,000 | $170,000 | 0.08% |
| Tradeworx Inc. | 16,704 | $57,000 | 0.05% |
| LMR Partners LLP | 103,643 | $352,000 | 0.05% |